Compare Unichem Lab with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB LUPIN UNICHEM LAB/
LUPIN
 
P/E (TTM) x -94.5 107.6 - View Chart
P/BV x 0.5 2.4 21.2% View Chart
Dividend Yield % 2.7 0.0 -  

Financials

 UNICHEM LAB   LUPIN
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
LUPIN
Mar-19
UNICHEM LAB/
LUPIN
5-Yr Chart
Click to enlarge
High Rs292986 29.6%   
Low Rs182720 25.3%   
Sales per share (Unadj.) Rs167.7369.5 45.4%  
Earnings per share (Unadj.) Rs-3.613.4 -27.1%  
Cash flow per share (Unadj.) Rs5.937.4 15.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.3303.7 122.6%  
Shares outstanding (eoy) m70.38452.49 15.6%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.42.3 61.2%   
Avg P/E ratio x-65.363.6 -102.6%  
P/CF ratio (eoy) x39.922.8 174.8%  
Price / Book Value ratio x0.62.8 22.7%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,680386,064 4.3%   
No. of employees `0002.617.7 14.7%   
Total wages/salary Rs m2,39331,513 7.6%   
Avg. sales/employee Rs Th4,535.29,453.8 48.0%   
Avg. wages/employee Rs Th919.81,782.0 51.6%   
Avg. net profit/employee Rs Th-98.2343.0 -28.6%   
INCOME DATA
Net Sales Rs m11,801167,182 7.1%  
Other income Rs m9843,640 27.0%   
Total revenues Rs m12,785170,822 7.5%   
Gross profit Rs m-83528,822 -2.9%  
Depreciation Rs m67410,850 6.2%   
Interest Rs m753,078 2.4%   
Profit before tax Rs m-60018,534 -3.2%   
Minority Interest Rs m0-89 0.0%   
Prior Period Items Rs m138 1.9%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m-3439,017 -3.8%   
Profit after tax Rs m-2566,066 -4.2%  
Gross profit margin %-7.117.2 -41.0%  
Effective tax rate %57.348.7 117.7%   
Net profit margin %-2.23.6 -59.7%  
BALANCE SHEET DATA
Current assets Rs m20,384138,536 14.7%   
Current liabilities Rs m5,02961,299 8.2%   
Net working cap to sales %130.146.2 281.7%  
Current ratio x4.12.3 179.3%  
Inventory Days Days10584 125.1%  
Debtors Days Days135112 120.0%  
Net fixed assets Rs m9,023127,516 7.1%   
Share capital Rs m141905 15.6%   
"Free" reserves Rs m26,058136,517 19.1%   
Net worth Rs m26,199137,422 19.1%   
Long term debt Rs m066,417 0.0%   
Total assets Rs m31,496279,494 11.3%  
Interest coverage x-7.07.0 -99.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.40.6 62.6%   
Return on assets %-0.63.3 -17.5%  
Return on equity %-1.04.4 -22.1%  
Return on capital %-2.08.9 -22.4%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18859,414 13.8%   
Fx outflow Rs m59622,282 2.7%   
Net fx Rs m7,59237,132 20.4%   
CASH FLOW
From Operations Rs m-3,27816,660 -19.7%  
From Investments Rs m-2,860-32,825 8.7%  
From Financial Activity Rs m-247,441 -0.3%  
Net Cashflow Rs m-4,690-8,724 53.8%  

Share Holding

Indian Promoters % 50.1 46.6 107.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 31.9 9.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.1 313.9%  
Shareholders   20,176 98,259 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SHASUN PHARMA  WYETH LTD  GSK PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 15, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS